MX2023010942A - Moduladores de sting (estimulador de genes de interferon). - Google Patents
Moduladores de sting (estimulador de genes de interferon).Info
- Publication number
- MX2023010942A MX2023010942A MX2023010942A MX2023010942A MX2023010942A MX 2023010942 A MX2023010942 A MX 2023010942A MX 2023010942 A MX2023010942 A MX 2023010942A MX 2023010942 A MX2023010942 A MX 2023010942A MX 2023010942 A MX2023010942 A MX 2023010942A
- Authority
- MX
- Mexico
- Prior art keywords
- sting
- stimulator
- modulators
- interferon genes
- compounds
- Prior art date
Links
- 101000643024 Homo sapiens Stimulator of interferon genes protein Proteins 0.000 title abstract 3
- 102100035533 Stimulator of interferon genes protein Human genes 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Abstract
En la presente se proporcionan compuestos de la Fórmula general (I): (ver Fórmula), y sales aceptables desde el punto de vista farmacéutico de estos, procesos para la preparación de estos compuestos, composiciones que contienen estos compuestos y los usos de estos compuestos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162640P | 2021-03-18 | 2021-03-18 | |
| US202163165459P | 2021-03-24 | 2021-03-24 | |
| PCT/IB2022/052300 WO2022195462A1 (en) | 2021-03-18 | 2022-03-15 | Modulators of sting (stimulator of interferon genes) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023010942A true MX2023010942A (es) | 2023-09-28 |
Family
ID=80819922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023010942A MX2023010942A (es) | 2021-03-18 | 2022-03-15 | Moduladores de sting (estimulador de genes de interferon). |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11964978B2 (es) |
| EP (1) | EP4308563A1 (es) |
| JP (1) | JP2024509982A (es) |
| KR (1) | KR20230146606A (es) |
| AU (1) | AU2022238001A1 (es) |
| BR (1) | BR112023017731A2 (es) |
| CA (1) | CA3213427A1 (es) |
| CL (1) | CL2023002737A1 (es) |
| CO (1) | CO2023012198A2 (es) |
| CR (1) | CR20230413A (es) |
| DO (1) | DOP2023000194A (es) |
| EC (1) | ECSP23070418A (es) |
| IL (1) | IL306034A (es) |
| MX (1) | MX2023010942A (es) |
| TW (1) | TWI829112B (es) |
| UY (1) | UY39676A (es) |
| WO (1) | WO2022195462A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023222644A1 (en) | 2022-05-18 | 2023-11-23 | F. Hoffmann-La Roche Ag | Pyrazole derivatives as sting agonists |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| AR076601A1 (es) | 2009-05-21 | 2011-06-22 | Chlorion Pharma Inc | Pirimidinas como agentes terapeuticos |
| RU2710717C2 (ru) | 2010-09-09 | 2020-01-10 | Пфайзер Инк. | Молекулы, связывающиеся с 4-1ВВ |
| TWI595006B (zh) | 2014-12-09 | 2017-08-11 | 禮納特神經系統科學公司 | 抗ｐｄ－１抗體類和使用彼等之方法 |
| EP3408294A1 (en) | 2016-01-25 | 2018-12-05 | Pfizer Inc. | Combination of an ox40 agonist and a 4-1bb agonist monoclonal antibody for treating cancer |
| JP2019510802A (ja) * | 2016-04-07 | 2019-04-18 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | タンパク質調節物質として有用な複素環アミド |
| CA3024482A1 (en) | 2016-05-19 | 2017-11-23 | Bayer Aktiengesellschaft | Macrocyclic indole derivatives |
| BR112019027127A2 (pt) * | 2017-06-22 | 2020-07-07 | Curadev Pharma Limited | moduladores de sting humano de molécula pequena |
| TWI741268B (zh) * | 2018-03-15 | 2021-10-01 | 美商輝瑞股份有限公司 | 干擾素基因刺激劑（ｓｔｉｎｇ）的環戊烷為主體之調節劑 |
| WO2020028565A1 (en) * | 2018-07-31 | 2020-02-06 | Incyte Corporation | Tricyclic heteraryl compounds as sting activators |
| MA55214A (fr) * | 2019-03-05 | 2022-01-12 | F Star Therapeutics Inc | Composés, compositions et procédés pour le traitement d'une maladie |
| EP3969438A1 (en) * | 2019-05-16 | 2022-03-23 | Stingthera, Inc. | Oxoacridinyl acetic acid derivatives and methods of use |
| GEP20237572B (en) | 2019-09-25 | 2023-11-27 | Pfizer | Polyheterocyclic modulators of sting (stimulator of interferon genes) |
-
2022
- 2022-03-11 US US17/693,197 patent/US11964978B2/en active Active
- 2022-03-15 IL IL306034A patent/IL306034A/en unknown
- 2022-03-15 EP EP22711651.4A patent/EP4308563A1/en active Pending
- 2022-03-15 BR BR112023017731A patent/BR112023017731A2/pt unknown
- 2022-03-15 MX MX2023010942A patent/MX2023010942A/es unknown
- 2022-03-15 CA CA3213427A patent/CA3213427A1/en active Pending
- 2022-03-15 CR CR20230413A patent/CR20230413A/es unknown
- 2022-03-15 KR KR1020237031579A patent/KR20230146606A/ko active Search and Examination
- 2022-03-15 JP JP2023556477A patent/JP2024509982A/ja active Pending
- 2022-03-15 WO PCT/IB2022/052300 patent/WO2022195462A1/en active Application Filing
- 2022-03-15 AU AU2022238001A patent/AU2022238001A1/en active Pending
- 2022-03-17 TW TW111109919A patent/TWI829112B/zh active
- 2022-03-17 UY UY0001039676A patent/UY39676A/es unknown
-
2023
- 2023-09-14 DO DO2023000194A patent/DOP2023000194A/es unknown
- 2023-09-14 CL CL2023002737A patent/CL2023002737A1/es unknown
- 2023-09-15 EC ECSENADI202370418A patent/ECSP23070418A/es unknown
- 2023-09-15 CO CONC2023/0012198A patent/CO2023012198A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CR20230413A (es) | 2023-10-13 |
| CO2023012198A2 (es) | 2023-11-30 |
| IL306034A (en) | 2023-11-01 |
| BR112023017731A2 (pt) | 2023-10-03 |
| TW202246262A (zh) | 2022-12-01 |
| UY39676A (es) | 2022-10-31 |
| KR20230146606A (ko) | 2023-10-19 |
| CL2023002737A1 (es) | 2024-04-01 |
| CA3213427A1 (en) | 2022-09-22 |
| US20220306641A1 (en) | 2022-09-29 |
| US11964978B2 (en) | 2024-04-23 |
| JP2024509982A (ja) | 2024-03-05 |
| EP4308563A1 (en) | 2024-01-24 |
| DOP2023000194A (es) | 2023-11-30 |
| ECSP23070418A (es) | 2023-10-31 |
| AU2022238001A1 (en) | 2023-09-14 |
| WO2022195462A1 (en) | 2022-09-22 |
| TWI829112B (zh) | 2024-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020013817A (es) | Compuestos de naftiridinona sustituidos utiles como activadores de celulas t. | |
| PH12020551486A1 (en) | Cyclopentane-based modulators of sting (stimulator of interferon genes) | |
| PH12020551717A1 (en) | Dual atm and dna-pk inhibitors for use in anti-tumor therapy | |
| CR20210627A (es) | Derivados de benzisoxazol sulfonimada | |
| WO2019043634A3 (en) | CYCLIC DI-NUCLEOTIDES AS STIMULATORS OF INTERFERON GENE MODULATORS | |
| MX2020010407A (es) | Benzotiofenos y compuestos relacionados como agonistas de sting. | |
| MX2022003633A (es) | Moduladores poliheterociclicos de sting (estimulador de genes de interferon). | |
| WO2020113213A3 (en) | Cyclic pantetheine derivatives and uses thereof | |
| MX2022007369A (es) | Compuestos de quinolinonilo piperazina sustituidos utiles como activadores de celulas t. | |
| MX2022007130A (es) | Derivados de piperazina sustituidos utiles como activadores de celulas t. | |
| MX2021015188A (es) | Moduladores de nueva generacion del estimulador de genes de interferon (sting). | |
| MX2022006783A (es) | Nuevos derivados de metilquinazolinona. | |
| AU2020231934A8 (en) | Compounds useful in HIV therapy | |
| EP4249071A3 (en) | Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase | |
| EP4327877A3 (en) | Dual atm and dna-pk inhibitors for use in anti-tumor therapy | |
| MX2022004450A (es) | Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1. | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| MX2021014680A (es) | Derivado de benzotriazol. | |
| MX2023006504A (es) | Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo. | |
| MX2023010942A (es) | Moduladores de sting (estimulador de genes de interferon). | |
| MX2021004379A (es) | Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| JOP20220082A1 (ar) | مشتقات 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4 | |
| MX2023010823A (es) | Degradadores selectivos del receptor de estrogeno. | |
| CR20200615A (es) | Moduladores de sting (estimulador de genes de interferón) a base de ciclopentano | |
| NZ702684A (en) | Hexadepsipeptide analogues as anticancer compounds |